MedTrace Logo

Predictive Value of Reduced Keratinized Mucosa on the Secondary Prevention of Peri-implant Mucositis and Periimplantitis in Patients Attending Regular Supportive Peri-implant Care. A Longitudinal Analysis

NCT05804760 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2023-04-07

No results posted yet for this study

Summary

* Capture of the potential risk factor "lack of band of keratinised mucosa" over a period of up to 5 years.
* Recording of peri-implant inflammatory processes in study participants that are not recorded during normal tooth cleaning
* Registration of the extent of radiographic bone loss. Bone resorption through analysis of existing X-ray images
* Individual therapy recommendation/individual supportive peri-implant care in case of peri-implant inflammation
* The present study was specifically designed to investigate the effect of reduced width of keratinized mucosa (KM) on the secondary prevention of peri-implant mucositis and peri-implantitis in patients attending a supportive peri-implant care program (SPIC) over an observation period of up to five years.

Conditions

  • Peri-Implantitis
  • Peri-implant Mucositis
  • Lack of Keratinized Gingiva

Interventions

DIAGNOSTIC_TEST

Measurement of implant parameters

1. Examination of the inclusion criteria 2. Medical history/patient-specific data (smoking, tumour diseases, radiation, gender, number of implants, history of periodontitis). 3. Recording of implant-specific parameters (measurement depth at six sites per implant(probing depth/PD), bleeding and or pus on probing (BOP) at six measurement sites per implant, condition of the peri-implant mucosa using the modified plaque index(mPI) and the modified ginigiva index (mGI), measurement of the width of the keratinised mucosa(KM), type of denture, approximal plaque index (API), radiographically detectable bone resorption.

Sponsors & Collaborators

  • Hannover Medical School

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-02-12
Primary Completion
2020-10-23
Completion
2020-12-17

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05804760 on ClinicalTrials.gov